Intellipharmaceutics International Inc IPCIQ

Healthcare Biotechnology

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

GREY:IPCIQ - Post by User

Intellipharmaceutics International Inc > Did you notice?

<< Previous

Bullboard Posts

Next >>

Comment by FredZarfloonon Jan 17, 2020 12:08pm

190 Views

Post# 30565414

RE:Did you notice?

In 2015 "FDA completed its review of the (Regabatin) IND application and provided constructive input that we will use towards further development of the program."

Looks like it ain't doing much - and a search for Regabatin at US clinical trials turns up nothing.